Pluspunten
The ability to work from home, flexibility.
Minpunten
They cut everyones pay due to "COVID19" but then boast about winning 1 billion, yes BILLION worth of projects in Q2 2020. Obviously as a CRO we had more work during COVID rather than less, winning >80 vaccine trials. Their stock price is at an all time high. But they "cant afford" to pay their employees, the ones who are on the frontlines making the money for them. They have ruled out making up for these cutbacks in the future by way of bonuses or raises, leaving their employees disgruntled but their shareholders happy. Very unethical, and not the way to retain talent. Note that competitors have NOT taken similar action. With already high workloads and lots of overtime, the pay cuts have contributed to less satisfaction and higher turnover than usual, leaving higher workloads for the remaining staff, making them unhappy, then they leave, and its a vicious circle. If CROs were more realistic about resourcing, this wouldn't happen. They're burning out their staff very quickly.